|
|
Corporate
-
Open Offers
Daiichi Sankyo offer subscribed
New Delhi, Sept. 4
The Japanese drugmaker Daiichi Sankyo Co Ltd.'s
open offer for 20 per cent additional shares in
Ranbaxy Laboratories Ltd. is fully subscribed, according
to sources. Daiichi Sankyo's open offer for an additional
20 per cent stake in Ranbaxy at Rs 737 a share closed on
Thursday. Details of the transaction were not available.
Company officials declined to comment on the offer and
said that information may be released tomorrow. Earlier
in June, Daiichi Sankyo offered to buy a 34.8 per cent
stake in Ranbaxy from the Singh family.
Japan's thirdlargest drugmaker has also secured European antitrust
approval to buy Ranbaxy. The European Commission, the
27-nation European Union's antitrust regulator in
Brussels, announced the approval in a statement on
Thursday. Meanwhile, the Indian Government is yet to
approve the deal. The Foreign Investment Promotion
Board had initially cleared the proposal but later referred
it to the Cabinet Committee on Economic Affairs due to
procedural issues. -Our Bureau
Related Stories:
Ranbaxy - Open Offer: Accept
Daiichi Sankyo open offer for Ranbaxy from August 16
More Stories on :
Open Offers |
Pharmaceuticals |
Ranbaxy Laboratories Ltd
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
|